📰 Drug Loading News
Drug Loading News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Drug Loading. Real-time updates on events, politics, business and more.
August 10, 2022
Erythrocyte membrane-enveloped salvianolic acid B nanoparticles attenuate cerebral ischemia-reperfusion injury
July 28, 2022
PEGylated SLN as a Promising Approach for Lymphatic Delivery of Gefitinib to Lung Cancer
March 22, 2022
/PRNewswire/ -- The "Exosome Development and Manufacturing Services Market, 2022-2035" report has been added to ResearchAndMarkets.coms offering. The "Exosome...
January 31, 2022
Breast cancer affects more than one million women per year worldwide. Through this study, we develop a nanoparticle-based drug delivery system to target breast cancer cells. Aspirin has been found to inhibit thromboembolic diseases with its tumor-preventing activity. As a consequence, it relieves disease symptoms and severity. Here, mesoporous Silica Nanoparticles (MNP) have been used to deliver Aspirin to the tumor location. MNP-based Aspirin in folic acid (F)-conjugated Polydopamine (MNP-Asp-P...
December 23, 2021
A BAN nano drug delivery system PEG-FA@ZIF-8@BAN with a zeolite imidazole framework-8 as a carrier, which can achieve the response of folate receptor.
October 5, 2021
/PRNewswire/ -- According to the latest report published by DelveInsight, "Injectable Drug Delivery Devices Market & Competitive Landscape" will provide...
February 4, 2021
Cellular Uptake The cellular uptake properties of the proteins labeled with FITC were analyzed by flow cytometry. The uptake of HFtn by tumor cells was mediated by TfR1 has been proved previously. As shown in Figure 3, cellular uptake of HFtn was much higher than that of free FITC, which is probably attributed to the TfR1 receptor-mediated endocytosis. Significantly, the mean fluorescence intensity of FITC-tLyP-1-HFtn was approximately three-fold higher than FITC-HFtn, suggesting that the enhan...